Home Celgene's Revlimid improves survival in blood cancer patients
 

Keywords :   


Celgene's Revlimid improves survival in blood cancer patients

2013-07-12 07:30:47| Biotech - Topix.net

Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in blood cancer patients.

Tags: blood cancer patients survival

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 SP 4
23.1122SSS64UL-S
23.11
23.11725 TYPE H
23.11 3
23.11 Studiologic NumaCompact2
23.11Switch EL Pro
23.11 22
More »